Vol. 43 | No. 1 | January-June 2015 Back

Open Access

Clinical Profile of Patients with Chronic Venous Insufficiency in a Community-Based Population in the Philippines: National Nutrition and Health Survey

Maria Teresa B. Abola, Lilibeth M. Maravilla, David Raymund K. Salvador
Jun 2015 DOI 10.69944/pjc.d299ce9c5b

Abstract

There is a scarcity of data on the prevalence and presentations of chronic venous disease (CVD) and chronic venous insufficiency (CVI) among Asians. Our study population comprised 7,212 subjects surveyed during the last National Nutrition and Health Survey (NNHeS) in 2008. The previously validated Southern Tagalog Venous Insufficiency Questionnaire (STVIQ) was used by research assistants to identify patients with CVD. The survey found that 52.5% of the subjects had CVD, while only 1.6% had CVI. CVD is common in the Philippines. It is reported in approximately five out of 10 Filipinos, both as a symptomatic condition (about 60% report symptoms) and as manifested by visible veins. CVD is more common among women, and it increases in prevalence with age. It may lead to loss of productivity and greater healthcare costs. Early recognition and education may be necessary to increase awareness of this disorder. Early therapy may likewise be warranted to prevent its long-term debilitating sequelae. Increasing awareness of CVI and CVD among primary care physicians and other healthcare providers, as well as providing them with a low-cost clinical screening tool, will significantly contribute towards diminishing the burden of CVD. 

References
  1. Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA, Raffetto JD, Vasquez MA, Wakefield TW; Society for Vascular Surgery; American Venous Forum. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011. 53:2S-48S. 
  2. Nicolaides AN; Cardiovascular Disease Educational and Research Trust; European Society of Vascular Surgery; The International Angiology Scientific Activity Congress Organization; International Union of Angiology; Union Internationale de Phlebologie at the Abbaye des Vaux de Cernay. Investigation of chronic venous insufficiency: a consensus statement. Circulation 2000. 102:e126-63. 
  3. Kaplan RM, Criqui MH, Denenberg JO, Bergan J, Fronek A. Quality of life in patients with chronic venous disease: San Diego population study. J Vasc Surg 2003. 37:1047-53. 
  4. Criqui MH, Jamosmos M, Fronek A, Denenberg JO, Langer RD, Bergan J, Golomb BA. Chronic Venous Disease in an ethnically diverse population: The San Diego Population Study. Am J Epidemiol 2003. 158(5):448-56. 
  5. Evans CJ, Fowkes FG, Ruckley CV, Lee AJ. Prevalence of varicose veins and chronic venous insufficiency in men and women in the general population: Edinburgh Vein Study. J Epidemiol Community Health 1999. 53:149-53. 
  6. Maffei FH, Magaldi C, Pinho SZ, Lastoria S, Pinho W, Yoshida WB, Rollo HA. Varicose veins and chronic venous insufficiency in Brazil: prevalence among 1755 inhabitants of a country town. Int J Epidemiol 1986. 15(2):210-7. 
  7. Preziosi P, Galan P, Aissa M, Hercberg S, Boccalon H. Prevalence of venous insufficiency in French adults of the SUVIMAX cohort. SUpplémentation en VItamines et Minéraux AntioXydants. Int Angiol 1999. 18(2):171-5. 
  8. Robertson L, Evans C, Fowkes FG. Epidemiology of chronic venous disease. Phlebology 2008. 23(3):103-11. 
  9. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005. 15(3):175-84. 
  10. Sam RC, Hobbs SD, Darvall KA, Rehman A, Adam DJ, Silverman SH, Bradbury AW. Chronic venous disease in a cohort of healthy UK Asian men. Eur J Vasc Endovasc Surg 2007. 34(1):92-6. 
  11. Rabe E, Guex JJ, Puskas A, Scuderi A, Fernandez Quesada F; VCP Coordinators. Epidemiology of chronic venous disorders in geographically diverse populations: results from the Vein Consult Program. Int Angiol 2012. 31(2):105-15. 
  12. Maravilla L, Salvador D, Abola MT. National nutritional health survey on chronic venous disease. Abstract presented in the Annual Meeting of the Society of Vascular Medicine, USA, June 2013. 
  13. Kanchanabat B, Wongmahisorn Y, Stapanavatr W, Kanchanasuttirak P, Manomaiphiboon A. Clinical presentation and patterns of venous reflux in Thai patients with chronic venous insufficiency (CVI). Eur J Vasc Endovasc Surg 2010. 40:399-402. 
  14. Maravilla L, Salvador DRK, Librojo R, et al. The Southern Tagalog venous insufficiency questionnaire (unpublished). 
  15. Criqui MH, Denenberg JO, Bergan J, Langer RD, Fronek A. Risk factors for chronic venous disease: the San Diego Population Study. J Vasc Surg 2007. 46(2):331-7. 
  16. Rabe. E. Epidemiology of severe stages of chronic venous insufficiency in the Bonn Vein Study. Phlebolymphology 2007. 14(3):148. 
  17. Rabe E. Focus: identifying and accessing patients with chronic venous disease: the large-scale VCP International Study. Medicographia 2011. 33(3):320-4. 
  18. Ippolito E, Belcaro G, Dugall M, Cesarone MR, Feragalli B, Errichi BM, Gizzi G, Pellegrini L, Ledda A, Luzzi R, Ricci A, Bavera P, Hosoi M, Corsi M, Errichi S. Venoruton®: post thrombotic syndrome. Clinical improvement in venous insufficiency (signs and symptoms) with Venoruton®. A five-year, open-registry, efficacy study. Panminerva Med 2011. 53(3 Suppl 1):13-9.
License

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which permits use, share — copy and redistribute the material in any medium or format, adapt — remix, transform, and build upon the material, as long as you give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes. If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original. You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc-sa/4.0/.